文献速递慢性肾脏病肾小球疾病

1型与2型糖尿病肾功能下降的代谢组学差异特征

Differential metabolomic signatures of declining renal function in Types 1 and 2 diabetes.
PubMed 文献 · Nephrol Dial Transplant · 2021-01-01

该研究比较了芬兰1型糖尿病队列(随访7年)与意大利2型糖尿病队列(随访3年)的血浆代谢组学,以每年eGFR下降最高四分位定义进展。进展者中2型糖尿病年eGFR下降幅度显著大于1型糖尿病。双变量随机森林和偏最小二乘法分析识别出与糖尿病类型及eGFR进展相关的代谢物,部分代谢物存在交互作用。

要点

  • 进展者中2型糖尿病年eGFR下降幅度显著大于1型糖尿病。
  • 双变量随机森林识别出22种与糖尿病类型相关的代谢物和13种与eGFR进展相关的分子。
  • 仅8种代谢物在双变量随机森林和偏最小二乘法分析中共同出现,代谢组学特征部分依赖于统计模型。

核心结论

  • 慢性肾脏病进展的代谢组学特征部分依赖于统计模型,双重分析识别出与1型和2型糖尿病进展性肾功能损害相关的分子。

研究设计与样本

  • 研究使用芬兰1型糖尿病和意大利2型糖尿病两个大型队列,分别随访至7年和3年。
  • 进展定义为年eGFR下降的最高四分位,采用单变量和双变量随机森林分析及双变量偏最小二乘法分析。

主要发现

  • 进展者中,2型糖尿病年eGFR下降为-5.3(3.0)mL/min/1.73 m2/年,1型糖尿病为-3.7(3.1)mL/min/1.73 m2/年,P=0.018。
  • 双变量随机森林提取出22种与糖尿病类型相关的代谢物(除5-甲硫腺苷、丙酮酸和β-羟基丙酮酸外,均在1型糖尿病中更高)和13种与eGFR进展相关的分子(除鞘磷脂外,均在进展者中更高)。
  • 三种代谢物(组氨酰苯丙氨酸、亮氨酰苯丙氨酸、色氨酰天冬酰胺)显示疾病类型与进展之间的显著交互作用。
  • 仅8种代谢物在双变量随机森林和偏最小二乘法分析中共同出现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic kidney disease (CKD) shows different clinical features in Types1 (T1D) and 2 diabetes (T2D). Metabolomics have recently provided useful contribution to the identification of biomarkers of CKD progression in either form of the disease. However, no studies have so far compared plasma metabolomics between T1D and T2D in order to identify differential signatures of progression of estimated glomerular filtration rate (eGFR) decline. METHODS: We used two large cohorts of T1D (from Finland) and T2D (from Italy) patients followed up to 7 and 3 years, respectively. In both groups, progression was defined as the top quartile of yearly decline in eGFR. Pooled data from the two groups were analysed by univariate and bivariate random forest (RF), and confirmed by bivariate partial least squares (PLS) analysis, the response variables being type of diabetes and eGFR progression. RESULTS: In progressors, yearly eGFR loss was significantly larger in T2D [-5.3 (3.0), median (interquartile range)mL/min/1.73 m2/year] than T1D [-3.7 (3.1) mL/min/1.73 m2/year ; P = 0.018]. Out of several hundreds, bivariate RF extracted 22 metabolites associated with diabetes type (all higher in T1D than T2D except for 5-methylthioadenosine, pyruvate and β-hydroxypyruvate) and 13 molecules associated with eGFR progression (all higher in progressors than non-progressors except for sphyngomyelin). Three of the selected metabolites (histidylphenylalanine, leucylphenylalanine, tryptophylasparagine) showed a significant interaction between disease type and progression. Only eight metabolites were common to both bivariate RF and PLS. CONCLUSIONS: Identification of metabolomic signatures of CKD progression is partially dependent on the statistical model. Dual analysis identified molecules specifically associated with progressive renal impairment in both T1D and T2D.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Manca ML, Solini A, Haukka JK, et al. Differential metabolomic signatures of declining renal function in Types 1 and 2 diabetes. Nephrol Dial Transplant. 2021. PMID: 32995893. doi:10.1093/ndt/gfaa175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。